- Home
- ENGN vs NEWT Comparison
ENGN vs NEWT Comparison
Compare ENGN & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENGN
- NEWT
- Stock Information
- Founded
- ENGN 1999
- NEWT 1998
- Country
- ENGN Canada
- NEWT United States
- Employees
- ENGN N/A
- NEWT N/A
- Industry
- ENGN
- NEWT Major Banks
- Sector
- ENGN
- NEWT Finance
- Exchange
- ENGN Nasdaq
- NEWT Nasdaq
- Market Cap
- ENGN 379.3M
- NEWT 316.7M
- IPO Year
- ENGN N/A
- NEWT N/A
- Fundamental
- Price
- ENGN $8.54
- NEWT $10.83
- Analyst Decision
- ENGN Buy
- NEWT Hold
- Analyst Count
- ENGN 7
- NEWT 4
- Target Price
- ENGN $20.29
- NEWT $13.25
- AVG Volume (30 Days)
- ENGN 361.4K
- NEWT 214.2K
- Earning Date
- ENGN 09-11-2025
- NEWT 10-29-2025
- Dividend Yield
- ENGN N/A
- NEWT 7.02%
- EPS Growth
- ENGN N/A
- NEWT 21.23
- EPS
- ENGN N/A
- NEWT 2.01
- Revenue
- ENGN N/A
- NEWT $364,004,000.00
- Revenue This Year
- ENGN N/A
- NEWT N/A
- Revenue Next Year
- ENGN N/A
- NEWT $12.40
- P/E Ratio
- ENGN N/A
- NEWT $5.38
- Revenue Growth
- ENGN N/A
- NEWT 20.91
- 52 Week Low
- ENGN $2.65
- NEWT $9.12
- 52 Week High
- ENGN $10.35
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- ENGN 60.29
- NEWT 40.22
- Support Level
- ENGN $8.49
- NEWT $10.30
- Resistance Level
- ENGN $8.85
- NEWT $11.11
- Average True Range (ATR)
- ENGN 0.85
- NEWT 0.33
- MACD
- ENGN 0.02
- NEWT -0.04
- Stochastic Oscillator
- ENGN 63.96
- NEWT 44.80
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.